zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials za sistemsko uporabo, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
tygacil
pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibacterials za sistemsko uporabo, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti. ustrezno uporabo protibakterijsko agenti.
zerbaxa
merck sharp & dohme b.v. - ceftolozane sulfat, tazobactam natrijev - bakterijske okužbe - antibacterials za sistemsko uporabo, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
monkasta 4 mg žvečljive tablete
krka, d.d., novo mesto - montelukast - žvečljiva tableta - montelukast 4 mg / 1 tableta - montelukast
flutikazonpropionat gsk 50 mikrogramov/vpih pršilo za nos, suspenzija
glaxosmithkline consumer healthcare (uk) trading limited - flutikazonpropionat - pršilo za nos, suspenzija - flutikazonpropionat 50 µg / 1 vpih - flutikazon
opatanol
novartis europharm limited - olopatadinijev klorid - konjunktivitis, alergični - oftalmologi - zdravljenje očesnih znakov in simptomov sezonskega alergijskega konjunktivitisa.
tigeciklin sandoz 50 mg prašek za raztopino za infundiranje
sandoz d.d. - tigeciklin - prašek za raztopino za infundiranje - tigeciklin 50 mg / 1 viala - tigeciklin
tigecycline accord
accord healthcare s.l.u. - tigecycline - soft tissue infections; intraabdominal infections; bacterial infections; skin diseases, infectious - antibacterials za sistemsko uporabo, - tygecycline soglasju je navedeno v odrasle in otroke, starejše od osem let za zdravljenje naslednjih okužb (glej točki 4. 4 in 5. 1):zapleteno, kože in mehkih tkiv, okužbe (cssti), razen diabetično stopalo okužbe (glejte poglavje 4. 4)zapletena znotraj trebušne okužb (ciai)tygecycline soglasju naj se uporablja le v primerih, ko druge alternativne antibiotiki niso primerni (glej točki 4. 4, 4. 8 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
mofenstra 4 mg zrnca
lek d.d. - montelukast - zrnca - montelukast 4 mg / 1 vrečica - montelukast
moksifloksacin stada 400 mg/250 ml raztopina za infundiranje
stada arzneimittel ag - moksifloksacin - raztopina za infundiranje - moksifloksacin 1,6 mg / 1 ml - moksifloksacin